Found: 37
Select item for more details and to access through your institution.
GlaxoSmithKline responds to the consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
- Published in:
- 2009
- By:
- Publication type:
- Letter
The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects.
- Published in:
- Pharmacology Research & Perspectives, 2018, v. 6, n. 2, p. 1, doi. 10.1002/prp2.327
- By:
- Publication type:
- Article
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 562, doi. 10.1002/cpdd.1090
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1419, doi. 10.1002/cpdd.1029
- By:
- Publication type:
- Article
A Randomized, Placebo‐ and Positive‐Controlled, Single‐Dose, Crossover Thorough QT/QTc Study Assessing the Effect of Daprodustat on Cardiac Repolarization in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 627, doi. 10.1002/cpdd.342
- By:
- Publication type:
- Article
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1890, doi. 10.1093/ndt/gfac342
- By:
- Publication type:
- Article
ASCEND-ND trial: study design and participant characteristics.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 11, p. 2157, doi. 10.1093/ndt/gfab318
- By:
- Publication type:
- Article
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 5, p. 960, doi. 10.1093/ndt/gfab065
- By:
- Publication type:
- Article
Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 7, p. 739, doi. 10.1002/cpdd.1257
- By:
- Publication type:
- Article
A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-na ïve type 2 diabetes mellitus patients
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 11, p. 1036, doi. 10.1111/j.1463-1326.2011.01461.x
- By:
- Publication type:
- Article
Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 6, p. 643, doi. 10.1111/j.1463-1326.2006.00648.x
- By:
- Publication type:
- Article
Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 6, p. 650, doi. 10.1111/j.1463-1326.2006.00659.x
- By:
- Publication type:
- Article
Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Anemia and mortality in patients with nondialysis-dependent chronic kidney disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury.
- Published in:
- Skeletal Muscle, 2018, v. 8, n. 1, p. N.PAG, doi. 10.1186/s13395-018-0179-5
- By:
- Publication type:
- Article
Posttranslational modification of ras proteins: Detection of a modification prior to fatty acid acylation and cloning of a gene responsible for the modification.
- Published in:
- Journal of Cellular Biochemistry, 1988, v. 36, n. 3, p. 261, doi. 10.1002/jcb.240360307
- By:
- Publication type:
- Article
Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy.
- Published in:
- Diabetes & Vascular Disease Research, 2006, v. 3, n. 3, p. 189, doi. 10.3132/dvdr.2006.029
- By:
- Publication type:
- Article
Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2006, v. 29, n. 2, p. 345, doi. 10.2337/diacare.29.02.06.dc05-1626
- By:
- Publication type:
- Article
Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 5, p. 693, doi. 10.1093/ckj/sfz013
- By:
- Publication type:
- Article
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 1, p. 139, doi. 10.1093/ckj/sfy014
- By:
- Publication type:
- Article
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 1, p. 129, doi. 10.1093/ckj/sfy013
- By:
- Publication type:
- Article
Normalization of skeletal muscle glycogen synthesis and glycolysis in rosiglitazone-treated Zucker fatty rats: an in vivo nuclear magnetic resonance study.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Commentary on 'case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2009, v. 18, n. 12, p. 1244, doi. 10.1002/pds.1840
- By:
- Publication type:
- Article
A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14 237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2008, v. 17, n. 8, p. 769, doi. 10.1002/pds.1615
- By:
- Publication type:
- Article
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
- Published in:
- American Journal of Nephrology, 2023, v. 54, n. 1/2, p. 1, doi. 10.1159/000528696
- By:
- Publication type:
- Article
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial.
- Published in:
- American Journal of Nephrology, 2021, v. 52, n. 1, p. 26, doi. 10.1159/000513103
- By:
- Publication type:
- Article
Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Response to Nathan et al.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes.
- Published in:
- Diabetes Care, 2009, v. 32, n. 5, p. e58, doi. 10.2337/dc09-0125
- By:
- Publication type:
- Article
Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan.
- Published in:
- Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1065, doi. 10.1111/1744-9987.13839
- By:
- Publication type:
- Article
Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients.
- Published in:
- Therapeutic Apheresis & Dialysis, 2021, v. 25, n. 6, p. 979, doi. 10.1111/1744-9987.13686
- By:
- Publication type:
- Article
A 24‐Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients.
- Published in:
- Therapeutic Apheresis & Dialysis, 2020, v. 24, n. 2, p. 108, doi. 10.1111/1744-9987.12962
- By:
- Publication type:
- Article
Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients.
- Published in:
- BMC Nephrology, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12882-015-0138-x
- By:
- Publication type:
- Article
Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article